Central icv injection of fibroblast growth factor 1 (FGF1) induces diabetes remission in animal models of T2DM in a process mediated by tanycyte activation that enhances insulin-independent glucose clearance [56,113]. Here, FGF1 is linked to type 2 diabetes mellitus.